Yingxue Su

Title: Yingxue Su and Ophthalmic Pharmaceutical Innovation.

Introduction

Yingxue Su is an inventor associated with Guangzhou, China. His work includes a pharmaceutical composition intended for the prevention or treatment of cataracts.

Latest Patents

Su is associated with 1 patent, titled “Pharmaceutical Composition, Preparation Method Therefor and Application Thereof.” The invention describes a composition containing a compound represented by Formula I, hydroxypropyl methyl cellulose, benzalkonium chloride, and a pH regulator. It also describes a preparation method and the composition’s use in medicines for preventing or treating cataracts.

According to the patent description, the composition is designed for stability under light exposure and high temperatures, allowing storage at room temperature. Its pH and osmotic pressure are intended to be close to those of the intraocular environment, while its uniform particle-size distribution is intended to support patient comfort.

Career Highlights

Su is associated with Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. and Ocusun Ophthalmic Pharmaceutical (Guangzhou) Co., Ltd. His patent work reflects a focus on ophthalmic pharmaceutical formulations and potential cataract treatments.

Collaborations

Yandong Wang and Chen Cao are identified as Su’s coworkers.

Conclusion

Yingxue Su’s patent describes an ophthalmic pharmaceutical composition developed with stability, convenient storage, and patient comfort in mind, and intended for potential use in preventing or treating cataracts.